EXELON 13.3 MG/24HR PATCH

rivastigmine
$22.0078per EA

Strength

13.3 mg/24h

Manufacturer

Sandoz Inc.

NDC

66758014431

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

12/3/2025

Active Ingredients

RIVASTIGMINE

Approval Type

New Drug (NDA)

FDA Application

NDA022083

On Market Since

7/6/2007

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

N/A